Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202405467152740Phase 2Completed
Phase 2, open-label trial of levobupivacaine in coronary arteriosclerosis (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Extubation time. Started Oct 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202405467152740.